Jump to content

From journals and scientific sources

Primary sources for information and statistics.

323 topics in this forum

  1. Official guides to tapering off psychiatric medications

    By Altostrata,
    • 0 replies
    • 3,468 views

  2. Before you start a topic in Journals....

    By Altostrata,
    • 0 replies
    • 1,796 views

  3. Liver Enzymes Cytochrome P450 Drug Interaction Tables

    By Altostrata,
    • 6 replies
    • 7,548 views

  4. Papers about prolonged antidepressant withdrawal syndrome

    By Altostrata,
    • 30 replies
    • 10,656 views

  5. Important topics in Journals and Scientific Sources

    By Altostrata,
    • 3 replies
    • 3,021 views

  6. Primary sources for data, records, papers

    By Altostrata,
    • 11 replies
    • 3,003 views

  7. Shapiro, 2018, Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs

    By bubbles,
    • 0 replies
    • 23 views

  8. Eveleigh, 2019, Patients' attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators

    By bubbles,
    • 0 replies
    • 43 views

  9. Fluyau, 2018 Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation

    By Altostrata,
    • 0 replies
    • 66 views

  10. Stockmann, 2019 What it was like to stop an antidepressant

    By bubbles,
    • 4 replies
    • 236 views

  11. Panayotis77 - Psychiatrist states 30% dosage disparity allowed by FDA

    Topic was moved to forum Events, controversies, actions

  12. Hengartner, 2019,Antidepressant withdrawal – the tide is finally turning

    By Linus,
    • 1 reply
    • 303 views

  13. Munkholm Munkholm, 2019, Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

    By Linus,
    • 7 replies
    • 313 views

  14. Ruhe, 2019 Comment on Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Onmyway,   
    • 7 replies
    • 232 views

  15. Fava, 2017 The Potential Role of Iatrogenic Comorbidity in the Interaction between Pharmacotherapy and Psychotherapy in Anxiety Disorders

    By Shep,
    • 0 replies
    • 118 views

  16. Fava, 2019 Iatrogenic Factors in Psychopathology

    By Shep,
    • 0 replies
    • 145 views

  17. Baldessarini, 2019 Effects of Treatment Discontinuation in Clinical Psychopharmacology.

    By Itzakadoozee,
    • 5 replies
    • 422 views

  18. Khan, 2019 Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

    By Altostrata,
    • 0 replies
    • 472 views

  19. Moncrieff, 2005 Rethinking models of psychotropic drug action.

    By Altostrata,
    • 0 replies
    • 209 views

  20. Récalt, 2019 Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.

    By Altostrata,
    • 0 replies
    • 225 views

  21. Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Henosis,
    • 28 replies
    • 2,327 views

  22. Veltri, 2015 Medication-induced hypokalemia

    By Altostrata,
    • 0 replies
    • 111 views

  23. Aydemir, 2018 SSRI Induced Apathy Syndrome

    By Altostrata,
    • 6 replies
    • 648 views

  24. Oehrberg, 1995 Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

    By Altostrata,
    • 0 replies
    • 145 views

  25. Maund, 2019 Managing Antidepressant Discontinuation: A Systematic Review.

    By Altostrata,
    • 0 replies
    • 230 views

  26. Reisman, 2017 Sexual Consequences of Post-SSRI Syndrome.

    By Altostrata,   
    • 0 replies
    • 138 views

  27. Bala, 2018 Post-SSRI Sexual Dysfunction: A Literature Review.

    By Altostrata,   
    • 0 replies
    • 162 views

  28. Papp, 2018 Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

    By Altostrata,
    • 3 replies
    • 308 views

  29. Khan, 2014 Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d.

    By Altostrata,
    • 0 replies
    • 141 views

  30. Jha, 2018 When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.

    By Altostrata,
    • 0 replies
    • 282 views

  31. Frankel, 2018 An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.

    By Andie,   
    • 2 replies
    • 232 views

  32. Attfield, 2016 Preparation of Lower Dosages of SNRI Antidepressants to Ameliorate Discontinuation Symptoms: Two Case Studies

    By Andie,   
    • 1 reply
    • 200 views

  33. Kaufmann, 2009 Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?

    By Altostrata,
    • 0 replies
    • 227 views

  34. Fornaro, 2018 The Emergence of loss of efficacy during Antidepressant Drug Treatment for Major Depressive Disorder: An Integrative Review of Evidence, Mechanisms, and Clinical Implications.

    By Altostrata,   
    • 1 reply
    • 212 views

  35. Davies, 2018 A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

    By Altostrata,
    • 3 replies
    • 650 views

  36. Berwian, 2017 Predicting relapse after antidepressant withdrawal - a systematic review.

    By Altostrata,
    • 5 replies
    • 352 views
×
×
  • Create New...

Important Information

Terms of Use Privacy Policy

  I accept